In patients with diabetes and albuminuria, the HRs for MACE, HHF, and CKD progression with triple combination therapy were estimated to be 0.65 (95% CI 0.550.76), 0.45 (95% CI 0.340.58), and 0.42 (95% CI 0.310.56), respectively, compared with those for conventional therapy alone (renin-angiotensin system inhibitors and classical risk factor management)
Here is the exact procedure, assuming you are using a standard U-100 insulin syringe
Increase fiber intake Fiber helps slow digestion and promote fullness
However, remember to be mindful of portion size
Yes, switching between GLP-1 medications is medically safe and commonly done
Covid-19: How Europe is approaching long covid